Iron Overload Impairs Autophagy: Effects of Rapamycin in Ameliorating Iron-Related Memory Deficits

• Published in: Molecular neurobiology Vol. 57; no. 2; pp. 1044 - 1054
• Main Authors: Uberti, Vanise Hallas, de Freitas, Betânia Souza, Molz, Patrícia, Bromberg, Elke, Schröder, Nadja
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2020; Springer Nature B.V
• Subjects: Aging; Autophagy; Biomedical and Life Sciences; Biomedicine; Carbonyl compounds; Cell Biology; Cognitive ability; Iron; Memory; Neonates; Neurobiology; Neurodegenerative diseases; Neurology; Neuroprotection; Neurosciences; Neurotoxicity; Phagocytosis; Rapamycin; Rodents; TOR protein; Iron; Rapamycin; Autophagy; Cognitive deficits; Neurodegenerative disorders
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-019-01794-4

Over the years, iron accumulation in specific brain regions has been observed in normal aging and related to the pathogenesis of neurodegenerative disorders. Many neurodegenerative diseases may involve cognitive dysfunction, and we have previously shown that neonatal iron overload induces permanent cognitive deficits in adult rats and exacerbates age-associated memory decline. Autophagy is a catabolic pathway involved in the removal of toxic protein aggregates, which are a hallmark of neurodegenerative events. In the present study, we investigated whether iron accumulation would interfere with autophagy and also sought to determine the effects of rapamycin-induced stimulation of autophagy in attenuating iron-related cognitive deficits. Male Wistar rats received a single daily oral dose of vehicle or iron carbonyl (30 mg/kg) at postnatal days 12–14. In adulthood, they received daily intraperitoneal injections of vehicle or rapamycin (0.25 mg/kg) for 14 days. Results showed that iron given in the neonatal period impaired inhibitory avoidance memory and induced a decrease in proteins critically involved in the autophagy pathway, Beclin-1 and LC3, in the hippocampus. Rapamycin in the adulthood reversed iron-induced memory deficits, decreased the ratio phospho-mTOR/total mTOR, and recovered LC3 II levels in iron-treated rats. Our results suggest that iron accumulation, as observed in neurodegenerative disorders, hinders autophagy, which might play a role in iron-induced neurotoxicity. Rapamycin, by inducing authophagy, was able to ameliorate iron-induced cognitive impairments. These findings support the use of rapamycin as a potential neuroprotective treatment against the cognitive decline associated to neurodegenerative disorders.